2025 HCPCS Code C7556
Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance, when performed
TAGS: peripheral therapeutic fluoroscopic diagnostic lavage alveolar endobronchial during bronchoscopic performed bronchial ultrasound rigid transendoscopic| Short Description | Bronch lavage w/ebus |
| Product Note | 0229 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 2024 |
| HCPCS Action Effective Date | January 01, 2024 |
| HCPCS Pricing Indicator Code | 99 - Value not established |
| HCPCS Type Of Service Code | 2 - Surgery |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C8932 - Mra, w/o dye, spinal canal
- C8933 - Mra, w/o&w/dye, spinal canal
- C8934 - Mra, w/dye, upper extremity
- C8935 - Mra, w/o dye, upper extr
- C8936 - Mra, w/o&w/dye, upper extr
- C8937 - Cad breast mri
- C8957 - Prolonged iv inf, req pump
- C9014 - Injection, cerliponase alfa
- C9015 - C-1 esterase, haegarda
- C9016 - Inj, triptorelin ext rel
- C9021 - Injection, obinutuzumab
- C9022 - Injection, elosulfase alfa
- C9023 - Inj testosterone undecanoate
- C9024 - Inj, daunorubicin-cytarabine
- C9025 - Injection, ramucirumab
- C9026 - Injection, vedolizumab
- C9027 - Injection, pembrolizumab
- C9028 - Inj. inotuzumab ozogamicin
- C9029 - Injection, guselkumab
- C9030 - Inj copanlisib
